Clonidine Patch
Product Images NDC 0378-0873

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 0378-0873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Clonidine Cross Section (017e8de4 474d 42cb B8ef A6b1577ae995 01)

Clonidine Cross Section (017e8de4 474d 42cb B8ef A6b1577ae995 01)
This diagram shows a solid matrix reservoir with an adhesive formulation and slit release liner. There is also a protective film included. The diagram explicitly states that it is not to scale.*
FDA Label Image

Patient Instructions Figure 1 (017e8de4 474d 42cb B8ef A6b1577ae995 03)

Patient Instructions Figure 1 (017e8de4 474d 42cb B8ef A6b1577ae995 03)
FDA Label Image

Patient Instructions Figure 2 (017e8de4 474d 42cb B8ef A6b1577ae995 04)

Patient Instructions Figure 2 (017e8de4 474d 42cb B8ef A6b1577ae995 04)
This text is a warning label for a medical patch that does not contain active medication. It advises the user to apply the patch and cover it with the adhesive cover if necessary. It also mentions that there are patient instructions for use. The patch contains medication and a cover, which is provided in case the patch becomes loose.*
FDA Label Image

Patient Instructions Figure 3 (017e8de4 474d 42cb B8ef A6b1577ae995 05)

Patient Instructions Figure 3 (017e8de4 474d 42cb B8ef A6b1577ae995 05)
FDA Label Image

Patient Instructions Figure 4 (017e8de4 474d 42cb B8ef A6b1577ae995 06)

Patient Instructions Figure 4 (017e8de4 474d 42cb B8ef A6b1577ae995 06)
FDA Label Image

Patient Instructions Figure 5 (017e8de4 474d 42cb B8ef A6b1577ae995 07)

Patient Instructions Figure 5 (017e8de4 474d 42cb B8ef A6b1577ae995 07)
FDA Label Image

Patient Instructions Figure 6 (017e8de4 474d 42cb B8ef A6b1577ae995 08)

Patient Instructions Figure 6 (017e8de4 474d 42cb B8ef A6b1577ae995 08)
This text appears to be a warning about a product called "conon1 oMESWECOVER". The warning states that the product does not contain active medication.*
FDA Label Image

Image 01

Image 01
This is a description of Clonidine Transdermal System, which is a type of skin patch used to deliver a medicine called Clonidine into the body over a week. Each system delivers 0.1mg Clonidine per day and contains 2.52mg Clonidine USP. It should only be used for transdermal purposes and kept out of reach of children. Dosage information can be found in the package insert, and the patch should be stored at 20-25°C. Lot and expiration information can also be recorded on the flap of the package.*
FDA Label Image

Image 02

Image 02
FDA Label Image

Image 03

Image 03
This is a description of the Clonidine Transdermal System, a medication used for transdermal delivery of 0.3 mg clonidine per day over one week. The system contains 7.56 g of clonidine, and the inactive components are colloidal silicon dioxide, mineral oil, pigmented polyethylene/polyester film, polyisobutylene, and silicone/polyester film. It is programmed for in vivo delivery and should only be used transdermally. Dosage information is included in the package insert, and the system should be stored between 20° to 25°C (68" to 77°F). The system can be found under the name Clonidine Transdermal System, USP (ECERTRY) or its corresponding NDC 0378-0873-99. The product should be kept out of reach of children.*
FDA Label Image

Image 04

Image 04
This appears to be a chemical formula for Clonidine, a medication used to treat high blood pressure and attention deficit hyperactivity disorder (ADHD).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.